These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2411951)

  • 41. Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus.
    Hsu SC; Chargelegue D; Obeid OE; Steward MW
    J Gen Virol; 1999 Jun; 80 ( Pt 6)():1401-1405. PubMed ID: 10374957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.
    Hussell T; Georgiou A; Sparer TE; Matthews S; Pala P; Openshaw PJ
    J Immunol; 1998 Dec; 161(11):6215-22. PubMed ID: 9834108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
    Srikiatkhachorn A; Braciale TJ
    J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes.
    Johnstone C; Guil S; Rico MA; García-Barreno B; López D; Melero JA; Del Val M
    J Gen Virol; 2008 Sep; 89(Pt 9):2194-2203. PubMed ID: 18753229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.
    Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM
    J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection.
    Chiba Y; Higashidate Y; Suga K; Honjo K; Tsutsumi H; Ogra PL
    J Med Virol; 1989 Jul; 28(3):133-9. PubMed ID: 2666570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Shifting immunodominance pattern of two cytotoxic T-lymphocyte epitopes in the F glycoprotein of the Long strain of respiratory syncytial virus.
    Johnstone C; de León P; Medina F; Melero JA; García-Barreno B; Val MD
    J Gen Virol; 2004 Nov; 85(Pt 11):3229-3238. PubMed ID: 15483236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection.
    Srikiatkhachorn A; Braciale TJ
    J Virol; 1997 Jan; 71(1):678-85. PubMed ID: 8985399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-mediated immune responses of lambs to challenge with bovine respiratory syncytial virus.
    Sharma AK; Woldehiwet Z
    Clin Exp Immunol; 1995 Aug; 101(2):288-94. PubMed ID: 7544251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low responder MHC alleles for Tc recognition of influenza nucleoprotein.
    Pala P; Askonas BA
    Immunogenetics; 1986; 23(6):379-84. PubMed ID: 3487504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes.
    Levely ME; Bannow CA; Smith CW; Nicholas JA
    J Virol; 1991 Jul; 65(7):3789-96. PubMed ID: 1710289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus.
    Bangham CR; McMichael AJ
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9183-7. PubMed ID: 3097646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.
    Olson MR; Varga SM
    J Immunol; 2007 Oct; 179(8):5415-24. PubMed ID: 17911628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection.
    DiNapoli JM; Murphy BR; Collins PL; Bukreyev A
    Virol J; 2008 Sep; 5():105. PubMed ID: 18816384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.
    Li H; Callahan C; Citron M; Wen Z; Touch S; Monslow MA; Cox KS; DiStefano DJ; Vora KA; Bett A; Espeseth A
    PLoS One; 2017; 12(11):e0187642. PubMed ID: 29121080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neonatal tolerance of major histocompatibility complex antigens alters Ir gene control of the cytotoxic T cell response to vaccinia virus.
    Müllbacher A; Blanden RV; Brenan M
    J Exp Med; 1983 Apr; 157(4):1324-38. PubMed ID: 6220111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection.
    Chang J; Choi SY; Jin HT; Sung YC; Braciale TJ
    J Immunol; 2004 Jan; 172(1):503-8. PubMed ID: 14688360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.